Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
182,917,028
Total 13F shares
14,061,056
Share change
-134,274
Total reported value
$456,556,375
Price per share
$32.47
Number of holders
45
Value change
-$3,399,325
Number of buys
27
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP Y95308105?
CUSIP Y95308105 identifies WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q3 2016

As of 30 Sep 2016, Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,061,056 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, LLC, FMR LLC, New Leaf Venture Partners, L.L.C., Foresite Capital Management III, LLC, Redmile Group, LLC, PERCEPTIVE ADVISORS LLC, Cormorant Asset Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, Clough Capital Partners L P, and BlackRock Fund Advisors. This page lists 45 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.